NEW YORK (GenomeWeb News) — Gene expression-analysis company MetriGenix has changed its name to Xceed Molecular.
 
CEO Michael Cohen said the new name “makes a simple, forthright statement” that reflects the company’s aspirations.
 
The Toronto-based company, founded in 2003, makes an automated microarray workstation and is developing services to accompany it. The company acquired GeneXP Biosciences two years ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.